View Report

Global Oligonucleotides Market Insights, Forecast to 2025

Publisher:    QYResearch

No. of Pages:    121

Report Code:   RnM2438658

1-user License :    $3,900.00

Site License :    $5,850.00

Enterprise License :    $7,800.00

Table of Content

Table of Contents

    Global Oligonucleotides Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications

      1 Study Coverage

      • 1.1 Oligonucleotides Product Introduction
      • 1.2 Key Market Segments in This Study
      • 1.3 Key Manufacturers Covered
      • 1.4 Market by Type
        • 1.4.1 Global Oligonucleotides Market Size Growth Rate by Type
        • 1.4.2 DNA Oligos
        • 1.4.3 RNA Oligos
      • 1.5 Market by Application
        • 1.5.1 Global Oligonucleotides Market Size Growth Rate by Application
        • 1.5.2 Pharmaceutical
        • 1.5.3 Research
        • 1.5.4 Diagnostic
      • 1.6 Study Objectives
      • 1.7 Years Considered

      2 Executive Summary

      • 2.1 Global Oligonucleotides Production
        • 2.1.1 Global Oligonucleotides Revenue 2014-2025
        • 2.1.2 Global Oligonucleotides Production 2014-2025
        • 2.1.3 Global Oligonucleotides Capacity 2014-2025
        • 2.1.4 Global Oligonucleotides Marketing Pricing and Trends
      • 2.2 Oligonucleotides Growth Rate (CAGR) 2019-2025
      • 2.3 Analysis of Competitive Landscape
        • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        • 2.3.2 Key Oligonucleotides Manufacturers
          • 2.3.2.1 Oligonucleotides Manufacturing Base Distribution, Headquarters
          • 2.3.2.2 Manufacturers Oligonucleotides Product Offered
          • 2.3.2.3 Date of Manufacturers Enter into Oligonucleotides Market
      • 2.4 Market Drivers, Trends and Issues

      3 Market Size by Manufacturers

      • 3.1 Oligonucleotides Production by Manufacturers
        • 3.1.1 Oligonucleotides Production by Manufacturers
        • 3.1.2 Oligonucleotides Production Market Share by Manufacturers
        • 3.1.3 Global Market Concentration Ratio (CR5 and HHI)
      • 3.2 Oligonucleotides Revenue by Manufacturers
        • 3.2.1 Oligonucleotides Revenue by Manufacturers (2014-2019)
        • 3.2.2 Oligonucleotides Revenue Share by Manufacturers (2014-2019)
        • 3.2.3 Global Oligonucleotides Market Concentration Ratio (CR10 and HHI)
      • 3.3 Oligonucleotides Price by Manufacturers
      • 3.4 Mergers & Acquisitions, Expansion Plans

      4 Oligonucleotides Production by Regions

      • 4.1 Global Oligonucleotides Production by Regions
        • 4.1.1 Global Oligonucleotides Production Market Share by Regions
        • 4.1.2 Global Oligonucleotides Revenue Market Share by Regions
      • 4.2 United States
        • 4.2.1 United States Oligonucleotides Production
        • 4.2.2 United States Oligonucleotides Revenue
        • 4.2.3 Key Players in United States
        • 4.2.4 United States Oligonucleotides Import & Export
      • 4.3 Europe
        • 4.3.1 Europe Oligonucleotides Production
        • 4.3.2 Europe Oligonucleotides Revenue
        • 4.3.3 Key Players in Europe
        • 4.3.4 Europe Oligonucleotides Import & Export
      • 4.4 China
        • 4.4.1 China Oligonucleotides Production
        • 4.4.2 China Oligonucleotides Revenue
        • 4.4.3 Key Players in China
        • 4.4.4 China Oligonucleotides Import & Export
      • 4.5 Japan
        • 4.5.1 Japan Oligonucleotides Production
        • 4.5.2 Japan Oligonucleotides Revenue
        • 4.5.3 Key Players in Japan
        • 4.5.4 Japan Oligonucleotides Import & Export
      • 4.6 Other Regions
        • 4.6.1 South Korea
        • 4.6.2 India
        • 4.6.3 Southeast Asia

      5 Oligonucleotides Consumption by Regions

      • 5.1 Global Oligonucleotides Consumption by Regions
        • 5.1.1 Global Oligonucleotides Consumption by Regions
        • 5.1.2 Global Oligonucleotides Consumption Market Share by Regions
      • 5.2 North America
        • 5.2.1 North America Oligonucleotides Consumption by Application
        • 5.2.2 North America Oligonucleotides Consumption by Countries
        • 5.2.3 United States
        • 5.2.4 Canada
        • 5.2.5 Mexico
      • 5.3 Europe
        • 5.3.1 Europe Oligonucleotides Consumption by Application
        • 5.3.2 Europe Oligonucleotides Consumption by Countries
        • 5.3.3 Germany
        • 5.3.4 France
        • 5.3.5 UK
        • 5.3.6 Italy
        • 5.3.7 Russia
      • 5.4 Asia Pacific
        • 5.4.1 Asia Pacific Oligonucleotides Consumption by Application
        • 5.4.2 Asia Pacific Oligonucleotides Consumption by Countries
        • 5.4.3 China
        • 5.4.4 Japan
        • 5.4.5 Korea
        • 5.4.6 India
        • 5.4.7 Australia
        • 5.4.8 Indonesia
        • 5.4.9 Thailand
        • 5.4.10 Malaysia
        • 5.4.11 Philippines
        • 5.4.12 Vietnam
      • 5.5 Central & South America
        • 5.5.1 Central & South America Oligonucleotides Consumption by Application
        • 5.5.2 Central & South America Oligonucleotides Consumption by Countries
        • 5.5.3 Brazil
      • 5.6 Middle East and Africa
        • 5.6.1 Middle East and Africa Oligonucleotides Consumption by Application
        • 5.6.2 Middle East and Africa Oligonucleotides Consumption by Countries
        • 5.6.3 Turkey
        • 5.6.4 GCC Countries
        • 5.6.5 Egypt
        • 5.6.6 South Africa

      6 Market Size by Type

      • 6.1 Global Oligonucleotides Breakdown Dada by Type
      • 6.2 Global Oligonucleotides Revenue by Type
      • 6.3 Oligonucleotides Price by Type

      7 Market Size by Application

      • 7.1 Overview
      • 7.2 Global Oligonucleotides Breakdown Dada by Application
        • 7.2.1 Global Oligonucleotides Consumption by Application
        • 7.2.2 Global Oligonucleotides Consumption Market Share by Application (2014-2019)

      8 Manufacturers Profiles

      • 8.1 Integrated DNA Technologies
        • 8.1.1 Integrated DNA Technologies Company Details
        • 8.1.2 Company Description
        • 8.1.3 Capacity, Production and Value of Oligonucleotides
        • 8.1.4 Oligonucleotides Product Description
        • 8.1.5 SWOT Analysis
      • 8.2 Agilent
        • 8.2.1 Agilent Company Details
        • 8.2.2 Company Description
        • 8.2.3 Capacity, Production and Value of Oligonucleotides
        • 8.2.4 Oligonucleotides Product Description
        • 8.2.5 SWOT Analysis
      • 8.3 Sigma-aldrich
        • 8.3.1 Sigma-aldrich Company Details
        • 8.3.2 Company Description
        • 8.3.3 Capacity, Production and Value of Oligonucleotides
        • 8.3.4 Oligonucleotides Product Description
        • 8.3.5 SWOT Analysis
      • 8.4 Eurofins Genomics
        • 8.4.1 Eurofins Genomics Company Details
        • 8.4.2 Company Description
        • 8.4.3 Capacity, Production and Value of Oligonucleotides
        • 8.4.4 Oligonucleotides Product Description
        • 8.4.5 SWOT Analysis
      • 8.5 L.G.C Biosearch Technologies
        • 8.5.1 L.G.C Biosearch Technologies Company Details
        • 8.5.2 Company Description
        • 8.5.3 Capacity, Production and Value of Oligonucleotides
        • 8.5.4 Oligonucleotides Product Description
        • 8.5.5 SWOT Analysis
      • 8.6 Eurogentec S.A
        • 8.6.1 Eurogentec S.A Company Details
        • 8.6.2 Company Description
        • 8.6.3 Capacity, Production and Value of Oligonucleotides
        • 8.6.4 Oligonucleotides Product Description
        • 8.6.5 SWOT Analysis
      • 8.7 Nitto Denko Avecia Inc
        • 8.7.1 Nitto Denko Avecia Inc Company Details
        • 8.7.2 Company Description
        • 8.7.3 Capacity, Production and Value of Oligonucleotides
        • 8.7.4 Oligonucleotides Product Description
        • 8.7.5 SWOT Analysis
      • 8.8 GenScript
        • 8.8.1 GenScript Company Details
        • 8.8.2 Company Description
        • 8.8.3 Capacity, Production and Value of Oligonucleotides
        • 8.8.4 Oligonucleotides Product Description
        • 8.8.5 SWOT Analysis
      • 8.9 BBI Life Sciences
        • 8.9.1 BBI Life Sciences Company Details
        • 8.9.2 Company Description
        • 8.9.3 Capacity, Production and Value of Oligonucleotides
        • 8.9.4 Oligonucleotides Product Description
        • 8.9.5 SWOT Analysis
      • 8.10 GeneDesign
        • 8.10.1 GeneDesign Company Details
        • 8.10.2 Company Description
        • 8.10.3 Capacity, Production and Value of Oligonucleotides
        • 8.10.4 Oligonucleotides Product Description
        • 8.10.5 SWOT Analysis
      • 8.11 TriLink BioTechnologies
      • 8.12 SGS DNA
      • 8.13 LC Sciences
      • 8.14 Twist Bioscience
      • 8.15 Creative Biogene
      • 8.16 General Biosystems

      9 Production Forecasts

      • 9.1 Oligonucleotides Production and Revenue Forecast
        • 9.1.1 Global Oligonucleotides Production Forecast 2019-2025
        • 9.1.2 Global Oligonucleotides Revenue Forecast 2019-2025
      • 9.2 Oligonucleotides Production and Revenue Forecast by Regions
        • 9.2.1 Global Oligonucleotides Revenue Forecast by Regions
        • 9.2.2 Global Oligonucleotides Production Forecast by Regions
      • 9.3 Oligonucleotides Key Producers Forecast
        • 9.3.1 United States
        • 9.3.2 Europe
        • 9.3.3 China
        • 9.3.4 Japan
      • 9.4 Forecast by Type
        • 9.4.1 Global Oligonucleotides Production Forecast by Type
        • 9.4.2 Global Oligonucleotides Revenue Forecast by Type

      10 Consumption Forecast

      • 10.1 Consumption Forecast by Application
      • 10.2 Oligonucleotides Consumption Forecast by Regions
      • 10.3 North America Market Consumption Forecast
        • 10.3.1 North America Oligonucleotides Consumption Forecast by Countries 2019-2025
        • 10.3.2 United States
        • 10.3.3 Canada
        • 10.3.4 Mexico
      • 10.4 Europe Market Consumption Forecast
        • 10.4.1 Europe Oligonucleotides Consumption Forecast by Countries 2019-2025
        • 10.4.2 Germany
        • 10.4.3 France
        • 10.4.4 UK
        • 10.4.5 Italy
        • 10.4.6 Russia
      • 10.5 Asia Pacific Market Consumption Forecast
        • 10.5.1 Asia Pacific Oligonucleotides Consumption Forecast by Countries 2019-2025
        • 10.5.2 China
        • 10.5.3 Japan
        • 10.5.4 Korea
        • 10.5.5 India
        • 10.5.6 Australia
        • 10.5.7 Indonesia
        • 10.5.8 Thailand
        • 10.5.9 Malaysia
        • 10.5.10 Philippines
        • 10.5.11 Vietnam
      • 10.6 Central & South America Market Consumption Forecast
        • 10.6.1 Central & South America Oligonucleotides Consumption Forecast by Country 2019-2025
        • 10.6.2 Brazil
      • 10.7 Middle East and Africa Market Consumption Forecast
        • 10.7.1 Middle East and Africa Oligonucleotides Consumption Forecast by Countries 2019-2025
        • 10.7.2 Middle East and Africa
        • 10.7.3 Turkey
        • 10.7.4 GCC Countries
        • 10.7.5 Egypt
        • 10.7.6 South Africa

      11 Upstream, Industry Chain and Downstream Customers Analysis

      • 11.1 Analysis of Oligonucleotides Upstream Market
        • 11.1.1 Oligonucleotides Key Raw Material
        • 11.1.2 Typical Suppliers of Key Oligonucleotides Raw Material
        • 11.1.3 Oligonucleotides Raw Material Market Concentration Rate
      • 11.2 Oligonucleotides Industry Chain Analysis
      • 11.3 Marketing & Distribution
      • 11.4 Oligonucleotides Distributors
      • 11.5 Oligonucleotides Customers

      12 Opportunities & Challenges, Threat and Affecting Factors

      • 12.1 Market Opportunities
      • 12.2 Market Challenges
      • 12.3 Porter's Five Forces Analysis

      13 Key Findings

        14 Appendix

        • 14.1 Research Methodology
          • 14.1.1 Methodology/Research Approach
            • 14.1.1.1 Research Programs/Design
            • 14.1.1.2 Market Size Estimation
            • 14.1.1.3 Market Breakdown and Data Triangulation
          • 14.1.2 Data Source
            • 14.1.2.1 Secondary Sources
            • 14.1.2.2 Primary Sources
        • 14.2 Author Details